SPONSORED CONTENT
TIP: Don’t assume your contract pricing is correct on every account just because it’s correct on one account.
Year: 2024
340B hospitals need new transparency requirements and program eligibility rules to ensure the sustainability of the program, Republican lawmakers said [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A key House subcommittee oversight hearing today on the 340B program will include a witness who previously said Congress should [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Vertex Pharmaceuticals has become the 33rd drugmaker to place 340B contract pharmacy restrictions, but the new policy exempts all six [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
All entities who participate in the 340B program are subject to an Office of Pharmacy Affairs (OPA) audit regardless of entity type, size or volume of transactions. For the last five years, HRSA’s OPA has been completing approximately 200 audits a year and
…
An influential drug industry group and a major drugmaker each filed lawsuits challenging West Virginia’s 340B contract pharmacy access law [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmaker UCB recently told 340B providers in Arkansas that it will exempt them from its contract pharmacy restrictions. In a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Generic and biosimilar drugmaker Sandoz recently added a drug used in conjunction with cancer treatments to its list of drugs [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The federal office tasked with overseeing the 340B program will brief covered entities and manufacturers next week on the administrative [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
In last month’s column, I wrote about a reprehensible campaign by 340B opponents to tie this vital drug discount program [...] …
